Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 12/20 | 0.62 |
| ▸ | GCGR | P47871 | 1/20 | 0.62 |
| ▸ | GIPR | P48546 | 1/20 | 0.62 |
| ▸ | TLR2 | O60603 | 4/20 | 0.59 |
| ▸ | KISS1R | Q969F8 | 3/20 | 0.58 |
| ▸ | CCKBR | P32239 | 1/20 | 0.58 |
| ▸ | ECE1 | P42892 | 1/20 | 0.57 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30631721 | 1.00 | GLP1R (0.62) | GLP1RGCGRGIPRTLR2KISS1R | |
| SCHEMBL11205934 | 0.92 | TLR2 (0.58) | GLP1RGCGRGIPRTLR2BACE1 | |
| SCHEMBL29983511 | 0.91 | GLP1R (0.62) | GLP1RGCGRGIPRCCKBRECE1 | |
| SCHEMBL29694498 | 0.91 | GLP1R (0.60) | GLP1RGCGRGIPRTLR2KISS1R | |
| SCHEMBL29360549 | 0.90 | GLP1R (0.66) | GLP1RGCGRGIPRTLR2CCKBR | |
| SCHEMBL38652639 | 0.89 | GLP1R (0.61) | GLP1RGCGRGIPRTLR2CCKBR | |
| SCHEMBL29393291 | 0.89 | GLP1R (0.69) | GLP1RGCGRGIPRTLR2KISS1R | |
| SCHEMBL29393860 | 0.88 | GLP1R (0.70) | GLP1RGCGRGIPRCCKBRECE1 | |
| SCHEMBL31666092 | 0.88 | GLP1R (0.61) | GLP1RGCGRGIPRCCKBRECE1 | |
| SCHEMBL31666091 | 0.88 | GLP1R (0.61) | GLP1RGCGRGIPRCCKBRECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022191252-A1 | METHOD FOR PRODUCING CYSTEINE KNOT PROTEIN | 住友ファーマ株式会社 | 2022-09-15 | — | — | WO | disclosed |